Evolent Health Inc Capital Reinvestment Ratio

Latest as of December 2025: 0.16x

Evolent Health Inc capital reinvestment ratio. Evolent Health Inc (EVH) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow ($48.80 Million) in capital expenditures ($7.76 Million). Check how aggressively does Evolent Health Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.16x
Capex / Operating Cash Flow

Operating Cash Flow

$48.80 Million
USD

Capital Expenditures

$7.76 Million
USD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Evolent Health Inc (2021–2025)

Capital reinvestment ratio of Evolent Health Inc from 2021 to 2025. This chart tracks Evolent Health Inc's Capital Reinvestment Ratio across 4 annual periods. Also explore net asset growth rate of Evolent Health Inc to track the company's year-over-year net asset growth rate.

Evolent Health Inc Capital Reinvestment Ratio by Year (2021–2025)

Evolent Health Inc capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Evolent Health Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.88x $38.84 Million $34.09 Million ▼ -33.8%
2024 1.33x $18.77 Million $24.89 Million ▲ +558.0%
2023 0.20x $142.58 Million $28.75 Million ▼ -68.7%
2021 0.64x $38.75 Million $24.98 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow